MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins

By K. Vickers, Brian T. Palmisano, Bassem M. Shoucri, R. Shamburek, A. Remaley. Nature Cell Biology, 2011

2,726 citations recorded by the source corpus.

Circulating microRNAs (miRNA) are relatively stable in plasma and are a new class of disease biomarkers. Here we present evidence that high-density lipoprotein (HDL) transports endogenous miRNAs and delivers them to recipient cells with functional targeting capabilities. Cellular export of miRNAs to HDL was demonstrated to be regulated by neutral sphingomyelinase. Reconstituted HDL injected into mice retrieved distinct miRNA profiles from normal and atherogenic models. HDL delivery of both exogenous and endogenous miRNAs resulted in the direct targeting of messenger RNA reporters. Furthermore, HDL-mediated delivery of miRNAs to recipient cells was demonstrated to be dependent on scavenger receptor class B type I. The human HDL–miRNA profile of normal subjects is significantly different from that of familial hypercholesterolemia subjects. Notably, HDL–miRNA from atherosclerotic subjects induced differential gene expression, with significant loss of conserved mRNA targets in cultured hepatocytes. Collectively, these observations indicate that HDL participates in a mechanism of intercellular communication involving the transport and delivery of miRNAs.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/4cf13467f7d38c2e182801d88be50d271289f37d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles (2014, neutral): “However, the extracellular milieu is more complex as several body fluids (especially serum/plasma) harbour extracellular RNA (exRNA) in other non-EV carriers, including protein complexes (AGO2) (4) and lipoproteins [HDL and LDL (5)].”
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. (2016, background): “In addition, they can be associated with HDL and other lipoprotein complexes (275).”
An overview of microRNAs (2015, neutral): “lipid exosomes protecting them from degradation[221-227].”
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper (2017, background): “Both LDL and HDL were shown to transport miRNA,[47] which may be co-iso-”
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease (2019, background): “A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and AGO2 phosphorylation, which leads to uncoupling of miRNAs from the complex, alters miRNA sorting and loading, as well as exosome release (McKenzie et al., 2016).”